Advances in nutritional research on regulatory T-cells

Nutrients

Volumn 5, Issue 11, 2013, Pages 4305-4315

  Kim, Wooki ^a   Lee, Hyungjae ^b  

^a Kyung Hee University   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Anti inflammatory; Immunology; Nutrition; Regulatory T cells; Tregs

Indexed keywords

EPIGALLOCATECHIN GALLATE; FOLIC ACID; ICOSAPENTAENOIC ACID; NARINGENIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYPHENOL; RETINOL; VITAMIN;

ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; COLITIS; DIET; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; NUTRITION; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FATTY ACIDS, OMEGA-3; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; POLYPHENOLS; T-LYMPHOCYTES, REGULATORY; VITAMINS;

EID: 84887161538     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu5114305     Document Type: Review

References (49)

1. Jager, A.; Kuchroo, V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 2010, 72, 173-184.
2. Stout, R.D.; Bottomly, K. Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J. Immunol. 1989, 142, 760-765.
3. Heinzel, F.P.; Sadick, M.D.; Mutha, S.S.; Locksley, R.M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 1991, 88, 7011-7015.
4. Chen, Z.; Lin, F.; Gao, Y.; Li, Z.; Zhang, J.; Xing, Y.; Deng, Z.; Yao, Z.; Tsun, A.; Li, B. FOXP3 and RORgammat: Transcriptional regulation of Treg and Th17. Int. Immunopharmacol. 2011, 11, 536-542.
5. Chang, Q.; Wang, Y.K.; Zhao, Q.; Wang, C.Z.; Hu, Y.Z.; Wu, B.Y. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J. Gastroenterol. Hepatol. 2012, 27, 273-278.
6. Murdaca, G.; Colombo, B.M.; Puppo, F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern. Emerg. Med. 2011, 6, 487-495.
7. Caprioli, F.; Pallone, F.; Monteleone, G. Th17 immune response in IBD: A new pathogenic mechanism. J. Crohn's Colitis 2008, 2, 291-295.
8. Seiderer, J.; Elben, I.; Diegelmann, J.; Glas, J.; Stallhofer, J.; Tillack, C.; Pfennig, S.; Jurgens, M.; Schmechel, S.; Konrad, A.; et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p. His161Arg polymorphism in IBD. Inflamm. Bowel Dis. 2008, 14, 437-445.
9. Basu, R.; O'Quinn, D.B.; Silberger, D.J.; Schoeb, T.R.; Fouser, L.; Ouyang, W.; Hatton, R.D.; Weaver, C.T. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37, 1061-1075.
10. Dardalhon, V.; Awasthi, A.; Kwon, H.; Galileos, G.; Gao, W.; Sobel, R.A.; Mitsdoerffer, M.; Strom, T.B.; Elyaman, W.; Ho, I.C.; et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 2008, 9, 1347-1355.
11. Veldhoen, M.; Uyttenhove, C.; van Snick, J.; Helmby, H.; Westendorf, A.; Buer, J.; Martin, B.; Wilhelm, C.; Stockinger, B. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9, 1341-1346.
12. Kaplan, M.H. Th9 cells: Differentiation and disease. Immunol. Rev. 2013, 252, 104-115.
13. Baker, P.J. Homeostatic control of antibody responses: A model based on the recognition of cell-associated antibody by regulatory T cells. Transplant. Rev. 1975, 26, 3-20.
14. Baumgart, M.; Tompkins, F.; Leng, J.; Hesse, M. Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J. Immunol. 2006, 176, 5374-5387.
15. Yuan, X.; Malek, T.R. Cellular and molecular determinants for the development of natural and induced regulatory T cells. Hum. Immunol. 2012, 73, 773-782.
16. Thornton, A.M.; Korty, P.E.; Tran, D.Q.; Wohlfert, E.A.; Murray, P.E.; Belkaid, Y.; Shevach, E.M. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 2010, 184, 3433-3441.
17. Himmel, M.E.; MacDonald, K.G.; Garcia, R.V.; Steiner, T.S.; Levings, M.K. Helios+ and Helios-cells coexist within the natural FOXP3+ T regulatory cell subset in humans. J. Immunol. 2013, 190, 2001-2008.
18. Curotto de Lafaille, M.A.; Lafaille, J.J. Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor? Immunity 2009, 30, 626-635.
19. Toda, A.; Piccirillo, C.A. Development and function of naturally occurring CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 2006, 80, 458-470.
20. Tanoue, T.; Honda, K. Induction of Treg cells in the mouse colonic mucosa: A central mechanism to maintain host-microbiota homeostasis. Semin. Immunol. 2012, 24, 50-57.
21. Kurzweil, V.; Tarangelo, A.; Oliver, P.M. Gastrointestinal microbiota do not significantly contribute to T cell activation or GI inflammation in Ndfip1-cKO mice. PLoS One 2012, 7, e34478.
22. Khounlotham, M.; Kim, W.; Peatman, E.; Nava, P.; Medina-Contreras, O.; Addis, C.; Koch, S.; Fournier, B.; Nusrat, A.; Denning, T.L.; et al. Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity 2012, 37, 563-573.
23. Koch, U.; Radtke, F. Mechanisms of T cell development and transformation. Annu. Rev. Cell Dev. Biol. 2011, 27, 539-562.
24. Fantini, M.C.; Dominitzki, S.; Rizzo, A.; Neurath, M.F.; Becker, C. In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells. Nat. Protoc. 2007, 2, 1789-1794.
25. Maden, M. Retinoid signalling in the development of the central nervous system. Nat. Rev. Neurosci. 2002, 3, 843-853.
26. Bai, A.; Lu, N.; Guo, Y.; Liu, Z.; Chen, J.; Peng, Z. All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J. Leukoc. Biol. 2009, 86, 959-969.
27. Wu, J.; Zhang, Y.; Liu, Q.; Zhong, W.; Xia, Z. All-trans retinoic acid attenuates airway inflammation by inhibiting Th2 and Th17 response in experimental allergic asthma. BMC Immunol. 2013, 14, 28.
28. Park, M.K.; Jhun, J.Y.; Lee, S.Y.; Oh, H.J.; Park, M.J.; Byun, J.K.; Yoon, B.Y.; Park, E.M.; Lee, D.G.; Kwok, S.K.; et al. Retinal attenuates inflammatory arthritis by reciprocal regulation of IL-17-producing T cells and Foxp3(+) regulatory T cells and the inhibition of osteoclastogenesis. Immunol. Lett. 2012, 148, 59-68.
29. Chang, J.; Thangamani, S.; Kim, M.H.; Ulrich, B.; Morris, S.M., Jr.; Kim, C.H. Retinoic acid promotes the development of Arg1-expressing dendritic cells for the regulation of T-cell differentiation. Eur. J. Immunol. 2013, 43, 967-978.
30. Kunisawa, J.; Hashimoto, E.; Ishikawa, I.; Kiyono, H. A pivotal role of vitamin B9 in the maintenance of regulatory T cells in vitro and in vivo. PLoS One 2012, 7, e32094.
31. Calder, P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol. 2012, 75, 645-662.
32. Cabre, E.; Manosa, M.; Gassull, M.A. Omega-3 fatty acids and inflammatory bowel diseases-A systematic review. Br. J. Nutr. 2012, 107 (Suppl. 2), 240-252.
33. Maroufyan, E.; Kasim, A.; Ebrahimi, M.; Loh, T.C.; Bejo, M.H.; Zerihun, H.; Hosseni, F.; Goh, Y.M.; Farjam, A.S. Omega-3 polyunsaturated fatty acids enrichment alters performance and immune response in infectious bursal disease challenged broilers. Lipids Health Dis. 2012, 11, 15.
34. Wall, R.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C. Fatty acids from fish: The anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr. Rev. 2010, 68, 280-289.
35. Sorokovoi, K.V.; Pogozheva, A.V.; Sergeeva, K.V. Effect of diet including omega-3 polyunsaturated fatty acids on the status of T-cell immunity in patients with ischemic heart disease and hyperproteinemia. Vopr. Pitan. 1997, 5, 6-8.
36. Terada, S.; Takizawa, M.; Yamamoto, S.; Ezaki, O.; Itakura, H.; Akagawa, K.S. Suppressive mechanisms of EPA on human T cell proliferation. Microbiol. Immunol. 2001, 45, 473-481.
37. Molvig, J.; Pociot, F.; Worsaae, H.; Wogensen, L.D.; Baek, L.; Christensen, P.; Mandrup-Poulsen, T.; Andersen, K.; Madsen, P.; Dyerberg, J.; et al. Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand. J. Immunol. 1991, 34, 399-410.
38. Simopoulos, A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991, 54, 438-463.
39. Curtis, C.L.; Rees, S.G.; Little, C.B.; Flannery, C.R.; Hughes, C.E.; Wilson, C.; Dent, C.M.; Otterness, I.G.; Harwood, J.L.; Caterson, B. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 2002, 46, 1544-1553.
40. Han, S.C.; Kang, G.J.; Ko, Y.J.; Kang, H.K.; Moon, S.W.; Ann, Y.S.; Yoo, E.S. Fermented fish oil suppresses T helper 1/2 cell response in a mouse model of atopic dermatitis via generation of CD4+CD25+Foxp3+ T cells. BMC Immunol. 2012, 13, 44.
41. Iwami, D.; Nonomura, K.; Shirasugi, N.; Niimi, M. Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells. Int. Immunopharmacol. 2011, 11, 384-389.
42. Kong, W.; Yen, J.H.; Ganea, D. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Brain Behav. Immun. 2011, 25, 872-882.
43. Yessoufou, A.; Ple, A.; Moutairou, K.; Hichami, A.; Khan, N.A. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J. Lipid Res. 2009, 50, 2377-2388.
44. Wang, H.K.; Yeh, C.H.; Iwamoto, T.; Satsu, H.; Shimizu, M.; Totsuka, M. Dietary flavonoid naringenin induces regulatory T cells via an aryl hydrocarbon receptor mediated pathway. J. Agric. Food Chem. 2012, 60, 2171-2178.
45. Assini, J.M.; Mulvihill, E.E.; Sutherland, B.G.; Telford, D.E.; Sawyez, C.G.; Felder, S.L.; Chhoker, S.S.; Edwards, J.Y.; Gros, R.; Huff, M.W. Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation and atherosclerosis in Ldlr-/-mice. J. Lipid Res. 2012, 54, 711-724.
46. Shi, Y.; Dai, J.; Liu, H.; Li, R.R.; Sun, P.L.; Du, Q.; Pang, L.L.; Chen, Z.; Yin, K.S. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can. J. Physiol. Pharmacol. 2009, 87, 729-735.
47. Wang, J.; Ren, Z.; Xu, Y.; Xiao, S.; Meydani, S.N.; Wu, D. Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. Am. J. Pathol. 2012, 180, 221-234.
48. Magrone, T.; Jirillo, E. Influence of polyphenols on allergic immune reactions: Mechanisms of action. Proc. Nutr. Soc. 2012, 71, 316-321.
49. Issazadeh-Navikas, S.; Teimer, R.; Bockermann, R. Influence of dietary components on regulatory T cells. Mol. Med. 2012, 18, 95-110